Mastever 100mg/ml 10ml Vial by Vermodje

Usage

1. Establish baseline blood work before first injection — lipid panel, full blood count, PSA, and fasting glucose — to create a reference point specific to your pre-protocol physiology.
2. Draw the required volume using a fresh 21–23G needle into a 1ml or 2ml luer-lock syringe; at 100mg/ml, a 0.5ml draw equals exactly 50mg, facilitating accurate low-dose measurement.
3. Inject intramuscularly into the glute, vastus lateralis, or deltoid using a 23–25G injection needle; rotate sites across each administration to minimise local tissue accumulation in extended TRT-adjacent protocols.
4. Administer every three to four days to align with the Drostanolone Propionate propionate ester's two-to-three-day half-life and maintain consistent serum androgen levels throughout the week.
5. At the six-week mark, repeat the same blood panel to assess lipid response, haematocrit change, and PSA movement; adjust dose or discuss continuation with your supervising physician based on these results.
6. At cycle end, taper gradually if used alongside exogenous testosterone, and initiate post-cycle or cruise-phase management according to your physician's guidance; the propionate ester clears systemically within approximately one week of the final injection.

Warnings

Frequently asked questions

Can Drostanolone Propionate be legitimately used alongside a standard testosterone replacement therapy protocol?

Yes, a subset of men on medically supervised TRT incorporate low-dose Drostanolone Propionate specifically to increase free testosterone availability and improve body composition without adding an aromatising compound. Typical adjunct doses in this context range from 100mg to 200mg per week. This approach is outside the scope of standard TRT guidelines and requires physician oversight, regular lipid monitoring, and individualised haematocrit tracking.

What specific health markers should men over 40 monitor when using Mastever in an anti-aging context?

Men over 40 should prioritise four monitoring categories: lipid panel (HDL suppression is measurable within six to eight weeks), full blood count for haematocrit and haemoglobin elevation, PSA for prostate health, and blood pressure. Baseline values should be established before starting and reassessed at the midpoint of any cycle. Frequency of monitoring increases with age, pre-existing cardiovascular risk, and concurrent TRT dose.

How does Drostanolone Propionate contribute to anti-aging outcomes beyond simple androgen replacement?

Drostanolone Propionate's DHT-mediated androgenic activity supports skeletal muscle protein turnover, which declines measurably after age 40. Its SHBG-competitive binding shifts more endogenous or exogenous testosterone into the free fraction, amplifying the androgenic signal at existing TRT doses. Additionally, its non-aromatising structure avoids additional oestrogen accumulation — a meaningful consideration for older men where oestrogen management is already part of their hormonal protocol.

How does drawing from a 100mg/ml 10ml vial compare to higher-concentration formulations when dialling in conservative TRT-adjacent doses?

At 100mg/ml, Mastever is the lowest-concentration Drostanolone Propionate option in this product group, which makes it the most precise for small weekly adjustments. A 0.5ml draw yields exactly 50mg and a 1ml draw yields 100mg — straightforward arithmetic that prevents measurement error when working in the 100–200mg weekly range common in anti-aging use. Higher-concentration formulations require sub-0.5ml draws for equivalent doses, increasing measurement sensitivity.

Does the 10ml multi-dose vial format suit extended anti-aging protocols, and how should it be stored after first use?

A 10ml vial at 100mg/ml contains 1,000mg total, supporting ten weeks at 100mg per week or five weeks at 200mg per week from a single vial — practical for the extended durations typical of anti-aging use. After the septum is first punctured, the vial should be stored upright at 15–25°C away from direct light; refrigeration is not required but reduces benzyl alcohol evaporation over time. Discard if particulate matter appears or the solution changes colour. (2) angle_used

Manufacturer

Vermodje SRL's Mastever product line sits within the company's injectable androgenic compound portfolio — a curated range of ester-specific DHT and testosterone derivatives that together address distinct therapeutic and performance applications. Within this portfolio, Mastever occupies the DHT-derivative category alongside other non-aromatising injectables, and its 100mg/ml concentration reflects a deliberate formulation decision: lower concentration per millilitre supports the conservative, precisely titrated dosing common in TRT-adjacent and anti-aging contexts where absolute dose accuracy matters more than volume economy. Vermodje's Republic of Moldova GMP licence governs the entire portfolio under a unified quality framework; however, each product line within the range — including Mastever — is validated independently, meaning compounding parameters, filtration specifications, and fill-weight tolerances are established and documented specifically for the Drostanolone Propionate formulation rather than carried over from adjacent products in the range.